Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Improved Outcomes Using Tacrolimus/Sirolimus for Graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
Biology of Blood and Marrow Transplantation, 09/30/09
Snyder DS et al. – The combination of tacrolimus/sirolimus +/– MTX for GVHD prophylaxis in the setting of RIC HCT for MF appears to reduce the incidence of severe acute GVHD and NRM, and leads to improved OS compared to CSA/MMF +/– MTX.
Related Articles
Association between exposure to topical tacrolimus or pimecrolimus and cancers
Annals of Pharmacotherapy, 11/16/09
Relevance Score: 92%
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids
Liver Transplantation, 11/03/09
Relevance Score: 89%
Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
Modern Rheumatology, 10/05/09
Relevance Score: 89%
Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children
Bone Marrow Transplantation, 11/19/09
Relevance Score: 88%
Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
Clinical Pharmacology & Therapeutics, 10/29/09
Relevance Score: 87%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Can antigen-specific regulatory T cells protect against graft vs. host disease and spare anti-malignancy alloresponse
Haematologica, 12/18/09
Differential Destruction of Stem Cells: Implications for Targeted Cancer Stem Cell Therapy
Cancer Research, 12/18/09
Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis
Annals of Hematology, 12/18/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/18/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


